table of content
1 Introduction to Research & Analysis Reports
1.1 Next Generation Sequencing (NGS) Software Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Sequencing (NGS) Software Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Sequencing (NGS) Software Overall Market Size
2.1 Global Next Generation Sequencing (NGS) Software Market Size: 2021 VS 2028
2.2 Global Next Generation Sequencing (NGS) Software Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Sequencing (NGS) Software Players in Global Market
3.2 Top Global Next Generation Sequencing (NGS) Software Companies Ranked by Revenue
3.3 Global Next Generation Sequencing (NGS) Software Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Sequencing (NGS) Software Companies in Global Market, by Revenue in 2021
3.5 Global Companies Next Generation Sequencing (NGS) Software Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Sequencing (NGS) Software Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Sequencing (NGS) Software Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Sequencing (NGS) Software Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Next Generation Sequencing (NGS) Software Market Size Markets, 2021 & 2028
4.1.2 Targeted Sequencing
4.1.3 Exome Sequencing
4.1.4 Other
4.2 By Type - Global Next Generation Sequencing (NGS) Software Revenue & Forecasts
4.2.1 By Type - Global Next Generation Sequencing (NGS) Software Revenue, 2017-2022
4.2.2 By Type - Global Next Generation Sequencing (NGS) Software Revenue, 2023-2028
4.2.3 By Type - Global Next Generation Sequencing (NGS) Software Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Sequencing (NGS) Software Market Size, 2021 & 2028
5.1.2 Hospitals and Clinics
5.1.3 Biopharma Companies
5.1.4 Government Agencies
5.1.5 Academic and Research Organizations
5.1.6 Other
5.2 By Application - Global Next Generation Sequencing (NGS) Software Revenue & Forecasts
5.2.1 By Application - Global Next Generation Sequencing (NGS) Software Revenue, 2017-2022
5.2.2 By Application - Global Next Generation Sequencing (NGS) Software Revenue, 2023-2028
5.2.3 By Application - Global Next Generation Sequencing (NGS) Software Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Next Generation Sequencing (NGS) Software Market Size, 2021 & 2028
6.2 By Region - Global Next Generation Sequencing (NGS) Software Revenue & Forecasts
6.2.1 By Region - Global Next Generation Sequencing (NGS) Software Revenue, 2017-2022
6.2.2 By Region - Global Next Generation Sequencing (NGS) Software Revenue, 2023-2028
6.2.3 By Region - Global Next Generation Sequencing (NGS) Software Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Next Generation Sequencing (NGS) Software Revenue, 2017-2028
6.3.2 US Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.3.3 Canada Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.3.4 Mexico Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Next Generation Sequencing (NGS) Software Revenue, 2017-2028
6.4.2 Germany Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.4.3 France Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.4.4 U.K. Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.4.5 Italy Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.4.6 Russia Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.4.7 Nordic Countries Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.4.8 Benelux Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Next Generation Sequencing (NGS) Software Revenue, 2017-2028
6.5.2 China Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.5.3 Japan Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.5.4 South Korea Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.5.5 Southeast Asia Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.5.6 India Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Next Generation Sequencing (NGS) Software Revenue, 2017-2028
6.6.2 Brazil Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.6.3 Argentina Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Sequencing (NGS) Software Revenue, 2017-2028
6.7.2 Turkey Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.7.3 Israel Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.7.4 Saudi Arabia Next Generation Sequencing (NGS) Software Market Size, 2017-2028
6.7.5 UAE Next Generation Sequencing (NGS) Software Market Size, 2017-2028
7 Players Profiles
7.1 BGI International
7.1.1 BGI International Corporate Summary
7.1.2 BGI International Business Overview
7.1.3 BGI International Next Generation Sequencing (NGS) Software Major Product Offerings
7.1.4 BGI International Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.1.5 BGI International Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Software Major Product Offerings
7.2.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.2.5 Thermo Fisher Scientific Key News
7.3 IBM
7.3.1 IBM Corporate Summary
7.3.2 IBM Business Overview
7.3.3 IBM Next Generation Sequencing (NGS) Software Major Product Offerings
7.3.4 IBM Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.3.5 IBM Key News
7.4 PerkinElmer
7.4.1 PerkinElmer Corporate Summary
7.4.2 PerkinElmer Business Overview
7.4.3 PerkinElmer Next Generation Sequencing (NGS) Software Major Product Offerings
7.4.4 PerkinElmer Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.4.5 PerkinElmer Key News
7.5 Illumina
7.5.1 Illumina Corporate Summary
7.5.2 Illumina Business Overview
7.5.3 Illumina Next Generation Sequencing (NGS) Software Major Product Offerings
7.5.4 Illumina Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.5.5 Illumina Key News
7.6 Beckman Coulter Genomics
7.6.1 Beckman Coulter Genomics Corporate Summary
7.6.2 Beckman Coulter Genomics Business Overview
7.6.3 Beckman Coulter Genomics Next Generation Sequencing (NGS) Software Major Product Offerings
7.6.4 Beckman Coulter Genomics Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.6.5 Beckman Coulter Genomics Key News
7.7 GATC Biotech Ag
7.7.1 GATC Biotech Ag Corporate Summary
7.7.2 GATC Biotech Ag Business Overview
7.7.3 GATC Biotech Ag Next Generation Sequencing (NGS) Software Major Product Offerings
7.7.4 GATC Biotech Ag Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.7.5 GATC Biotech Ag Key News
7.8 Bina Technologies
7.8.1 Bina Technologies Corporate Summary
7.8.2 Bina Technologies Business Overview
7.8.3 Bina Technologies Next Generation Sequencing (NGS) Software Major Product Offerings
7.8.4 Bina Technologies Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.8.5 Bina Technologies Key News
7.9 DNASTAR
7.9.1 DNASTAR Corporate Summary
7.9.2 DNASTAR Business Overview
7.9.3 DNASTAR Next Generation Sequencing (NGS) Software Major Product Offerings
7.9.4 DNASTAR Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.9.5 DNASTAR Key News
7.10 Genomatix Software
7.10.1 Genomatix Software Corporate Summary
7.10.2 Genomatix Software Business Overview
7.10.3 Genomatix Software Next Generation Sequencing (NGS) Software Major Product Offerings
7.10.4 Genomatix Software Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.10.5 Genomatix Software Key News
7.11 Partek Incorporated
7.11.1 Partek Incorporated Corporate Summary
7.11.2 Partek Incorporated Business Overview
7.11.3 Partek Incorporated Next Generation Sequencing (NGS) Software Major Product Offerings
7.11.4 Partek Incorporated Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.11.5 Partek Incorporated Key News
7.12 Real Time Genomics
7.12.1 Real Time Genomics Corporate Summary
7.12.2 Real Time Genomics Business Overview
7.12.3 Real Time Genomics Next Generation Sequencing (NGS) Software Major Product Offerings
7.12.4 Real Time Genomics Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.12.5 Real Time Genomics Key News
7.13 SoftGenetics LLC
7.13.1 SoftGenetics LLC Corporate Summary
7.13.2 SoftGenetics LLC Business Overview
7.13.3 SoftGenetics LLC Next Generation Sequencing (NGS) Software Major Product Offerings
7.13.4 SoftGenetics LLC Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.13.5 SoftGenetics LLC Key News
7.14 BioTeam
7.14.1 BioTeam Corporate Summary
7.14.2 BioTeam Business Overview
7.14.3 BioTeam Next Generation Sequencing (NGS) Software Major Product Offerings
7.14.4 BioTeam Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.14.5 BioTeam Key News
7.15 Qiagen N.V
7.15.1 Qiagen N.V Corporate Summary
7.15.2 Qiagen N.V Business Overview
7.15.3 Qiagen N.V Next Generation Sequencing (NGS) Software Major Product Offerings
7.15.4 Qiagen N.V Next Generation Sequencing (NGS) Software Revenue in Global Market (2017-2022)
7.15.5 Qiagen N.V Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
